Series B life sciences investors in New York
14 of 17 series b life sciences firms that report a preference say they can lead.
Can leadMostly followsNot reportedRecently active
Anders Hove, Isaac Manke+2 on the team
Seth L. Harrison, Anna Batarina+1 on the team
Behzad Aghazadeh, Mark Chin+2 on the team
George C. Petrocheilos, R. Jacob Vogelstein, Ph.D.+18 on the team
Nan Li, Zavain Dar+3 on the team
John H. Friedman, Kresimir Letinic+1 on the team
Bruce Roberts, Lisa Wisniewski+4 on the team
Brian Halak, Eric Heil+6 on the team
Ron Hunt, Vijay Lathi
Somu Subramaniam, Andrew Abrams+1 on the team
C. Scotland Stevens, Carl L. Gordon+7 on the team
Michael C. Diem, Anthony Barry+4 on the team
Ashley Friedman, James Gale+3 on the team
Ivan Jarry, Michael Shleifer+1 on the team
Shaun Rodriguez, PhD, Suzanne Angell+7 on the team
Geoffrey W. Smith, Amit Bansal+1 on the team
Alejandro Sanchez, Paul Enever
Paul Yook, Ryan Cinalli
Josh Fink, Themasap Khan+3 on the team
Avantika Daing, Deborah Jackson+4 on the team
Get series b life sciences investors in new york every Monday
Only the firms on this list that show new activity. Unsubscribe in one click.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckRelated lists
Series B investors in New York123Series B life sciences investors91Series B life sciences investors in California30Seed life sciences investors in New York26Series A life sciences investors in New York26Series B healthtech investors in New York22Series B fintech investors in New York18Series B consumer investors in New York18Series B enterprise software investors in New York16Pre-seed life sciences investors in New York15Series B life sciences investors in Massachusetts11Series B deep tech investors in New York11
Questions
How many series b life sciences investors in new york are there?
Mode VC tracks 20 firms on this list as of 2026-10-15. 0 have been active since September 2026.
What check size do series b life sciences investors in new york write?
The most reported band is $3M to $10M, reported by 8 firms on this list.
Which series b life sciences investors in new york lead rounds?
14 of 17 firms that report a preference say they can lead. Turn on "Leads rounds" to see only them.